Vantage Investment Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1K Hold
572
﹤0.01% 730
2018
Q2
$1K Hold
572
﹤0.01% 728
2018
Q1
$1K Hold
572
﹤0.01% 774
2017
Q4
$1K Hold
572
﹤0.01% 791
2017
Q3
$1K Hold
572
﹤0.01% 769
2017
Q2
$2K Hold
572
﹤0.01% 709
2017
Q1
$2K Hold
572
﹤0.01% 703
2016
Q4
$2K Hold
572
﹤0.01% 709
2016
Q3
$2K Hold
572
﹤0.01% 693
2016
Q2
$1K Hold
572
﹤0.01% 772
2016
Q1
$1K Sell
572
-48
-8% -$107 ﹤0.01% 762
2015
Q4
$2K Hold
620
﹤0.01% 700
2015
Q3
$2K Hold
620
﹤0.01% 708
2015
Q2
$2K Sell
620
-619
-50% -$2.4K ﹤0.01% 685
2015
Q1
$5K Buy
1,239
+619
+100% +$2.14K ﹤0.01% 686
2014
Q4
$2K Hold
620
﹤0.01% 703
2014
Q3
$2K Hold
620
﹤0.01% 655
2014
Q2
$2K Hold
620
﹤0.01% 649
2014
Q1
$2K Hold
620
﹤0.01% 606
2013
Q4
$2K Buy
+620
New +$1.87K ﹤0.01% 582

Other funds holding LCTX